"What we're doing now will change how we look at preventive care, diagnosis, and treatment." —Jacob Thaysen, PhD, CEO of Illumina. At our Gold Sponsor workshop today at #AGBT25, Jacob took the stage to share how multiomics is unlocking a deeper understanding of biology—one that goes beyond the genome to reveal the full picture of health and disease. From scaling spatial to accelerating single-cell research, we’re making these breakthroughs more accessible, more powerful, and more connected than ever before. The next frontier is here, and we’re building it together. https://bit.ly/3D7d2IM
👏👏👍👍❤️❤️
Interesting event
Clinical Professor of Medicine at University of California, San Diego I NACD Directorship Certified
2wClinicians and researchers alike are frequently challenged by the information that appears in silos. Piecemeal information is frustrating and is also less actionable. It is refreshing and commendable to have the Illumina roadmap provide a unified platform with the grit to integrate not only multiomics, NGS but also #AI and integrated multiomics software analyses. I am hopeful this helps realize the full potential of applied genomics. Also super excited by 5 billion single cell atlas, Perturbseq Broad Clinical Labs, Constellation and yes 5 base approach for methylation. Imagine the potentials in diagnostics, PGx, rare diseases, epitherapeutics and many more. #AGBT25